𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants

✍ Scribed by Barry C Johnson, Gary T Pauly, Ganesha Rai, Disha Patel, Joseph D Bauman, Heather L Baker, Kalyan Das, Joel P Schneider, David J Maloney, Eddy Arnold, Craig J Thomas, Stephen H Hughes


Book ID
119908039
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
648 KB
Volume
9
Category
Article
ISSN
1742-4690

No coin nor oath required. For personal study only.